Literature DB >> 18547492

Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.

D Minardi1, G Lucarini, A Filosa, G Milanese, A Zizzi, R Di Primio, R Montironi, G Muzzonigro.   

Abstract

Angiogenesis is a critical step in the growth, invasive progression and metastatic spread of solid tumors. We investigated the importance of tumor necrosis, and microvessel density (MVD), vascular endothelial growth factor (VEGF) and hypoxia inducible factor 1alpha (HIF-1alpha) immunohistochemical expression in a large series of clear cell renal carcinomas treated with radical nephrectomy and assessed the prognostic value of their expression in terms of patient survival at long-term followup. Fifty patients with clear cell RCC were examined. The features considered when evaluating the patients were age, tumor size and grade, intratumoral vascular and renal capsula invasion, histological necrosis, and MVD, vascular and tumoral cell VEGF, and vascular, tumoral cytoplasmic and nuclear HIF-1alpha expression on the histologic specimens. All considered parameters were correlated with patient specific survival. Mean age was 62.06 +/- 6.8 years. Median follow-up was 191.66 months; median survival was 120.86 months. Twenty-one patients developed metastases in the follow-up. Tumor necrosis, microvascular invasion and renal capsula infiltration are more likely to occur in high stage and grade RCC; cytoplasmic HIF-1alpha is highly expressed in high grade RCC. Survival is dependent upon tumor stage and grade, the presence of intratumoral vascular invasion and capsular infiltration, and tumor necrosis; MVD also resulted as being an important prognostic factor. VEGF and HIF-1alpha correlate with prognosis in high stage tumors where VEGF is the most important independent prognostic factor for cancer specific death. The histological and immunohistochemical parameters considered in our study can influence disease recurrence and survival in RCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547492     DOI: 10.1177/039463200802100225

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  21 in total

1.  Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas.

Authors:  Luciana Schultz; Alcides Chaux; Roula Albadine; Jessica Hicks; Jenny J Kim; Angelo M De Marzo; Mohamad E Allaf; Michael A Carducci; Ronald Rodriguez; Hans-Joerg Hammers; Pedram Argani; Victor E Reuter; George J Netto
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

Review 2.  Recent aspects of sunitinib therapy in patients with metastatic clear-cell renal cell carcinoma: a systematic review of the literature.

Authors:  Daniele Minardi; Luigi Quaresima; Matteo Santoni; Maristella Bianconi; Mario Scartozzi; Stefano Cascinu; Giovanni Muzzonigro
Journal:  Curr Urol Rep       Date:  2015-02       Impact factor: 3.092

3.  Influence of Exposure to Chronic Persistent Low-Dose Ionizing Radiation on the Tumor Biology of Clear-Cell Renal-Cell Carcinoma. An Immunohistochemical and Morphometric Study of Angiogenesis and Vascular Related Factors.

Authors:  Amparo Ruiz-Saurí; Gerardo Valencia-Villa; Alina Romanenko; Jesús Pérez; Raúl García; Heydi García; José Benavent; María Sancho-Tello; Carmen Carda; Antonio Llombart-Bosch
Journal:  Pathol Oncol Res       Date:  2016-05-07       Impact factor: 3.201

4.  Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments.

Authors:  Yue Zhang; Payal Kapur; Qing Yuan; Yin Xi; Ingrid Carvo; Sabina Signoretti; Ivan Dimitrov; Jeffrey A Cadeddu; Vitaly Margulis; Naira Muradyan; James Brugarolas; Ananth J Madhuranthakam; Ivan Pedrosa
Journal:  Clin Genitourin Cancer       Date:  2015-08-29       Impact factor: 2.872

5.  Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012.

Authors:  Yushi Zhang; Hongyan Yu; Hanzhong Li
Journal:  Int Urol Nephrol       Date:  2015-07-11       Impact factor: 2.370

6.  Three-dimensional analysis of tumour vascular corrosion casts using stereoimaging and micro-computed tomography.

Authors:  A A Folarin; M A Konerding; J Timonen; S Nagl; R B Pedley
Journal:  Microvasc Res       Date:  2010-03-19       Impact factor: 3.514

7.  Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity.

Authors:  Qing Yuan; Payal Kapur; Yue Zhang; Yin Xi; Ingrid Carvo; Sabina Signoretti; Ivan E Dimitrov; Jeffrey A Cadeddu; Vitaly Margulis; James Brugarolas; Ananth J Madhuranthakam; Ivan Pedrosa
Journal:  Clin Genitourin Cancer       Date:  2016-04-22       Impact factor: 2.872

8.  Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings.

Authors:  Rotem S Lanzman; Phil M Robson; Maryellen R Sun; Amish D Patel; Kimiknu Mentore; Andrew A Wagner; Elizabeth M Genega; Neil M Rofsky; David C Alsop; Ivan Pedrosa
Journal:  Radiology       Date:  2012-10-09       Impact factor: 11.105

Review 9.  The role of HIF1α in renal cell carcinoma tumorigenesis.

Authors:  Lorraine J Gudas; Leiping Fu; Denise R Minton; Nigel P Mongan; David M Nanus
Journal:  J Mol Med (Berl)       Date:  2014-06-12       Impact factor: 4.599

10.  Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma.

Authors:  Peter Beddy; Elizabeth M Genega; Long Ngo; Nicole Hindman; Jesse Wei; Andrea Bullock; Rupal S Bhatt; Michael B Atkins; Ivan Pedrosa
Journal:  Clin Genitourin Cancer       Date:  2013-10-19       Impact factor: 2.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.